MedTrace Logo

Auscultation and Pulse Oximetry Combined Screening of Neonatal Congenital Heart Disease

NCT05105880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40000

Last updated 2021-11-08

No results posted yet for this study

Summary

The investigators conducted this retrospective study in a large single center with an annual birth of more than 20,000 newborns, from January 1, 2018 to December 31, 2019, to confirm the applicability and accuracy of pulse oximetry (POX) combined cardio-auscultation to screen congenital heart disease for neonates.

Conditions

  • Congenital Heart Disease

Sponsors & Collaborators

  • Women and Children's Hospital of Linyi City

    lead OTHER

Eligibility

Min Age
0 Hours
Max Age
72 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-12-31
Completion
2020-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05105880 on ClinicalTrials.gov